Neuropathy News and Research

RSS

A three-drug diabetes pill outperformed dual therapy

Clinical trial results indicate that a fixed-dose combination of dapagliflozin, glimepiride, and metformin offers superior glycemic control in diabetes therapy.

4 Nov 2026

New exercise program helps people stay strong through cancer

When you’re going through cancer treatment or recovering afterwards, rest might seem like the best medicine.

3 Nov 2026

Affordable exercise program helps people with cancer rebuild strength

When you're going through cancer treatment or recovering afterwards, rest might seem like the best medicine. But research shows that exercise can also play an important role in managing cancer recovery.

2 Nov 2026

Taking a GLP-1 drug? Here's what the safety evidence really shows

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

26 Oct 2026

What young cancer survivors revealed about stress, exercise and friendship

Adolescent and young adult cancer survivors use exercise and social support to cope with stress, revealing insights for effective mental health interventions.

9 Oct 2026

$Vitamin B12 deficiency was linked to higher fracture hazard after 50$

Vitamin B12 deficiency was linked to higher fracture hazard after 50

A study links abnormal vitamin B12 levels to fracture risk, highlighting a complex relationship beyond simple deficiency in middle-aged and older adults.

2 Oct 2026

C-Path awards $1.7 million to advance five drug development projects

Critical Path Institute (C-Path) today announced that its Translational Therapeutics Accelerator has awarded $1,699,500 through five Bridging Research and Innovation in Drug Development Grants (BRIDGe).

22 Sep 2026

Personalized programs make no difference in preventing elderly falls

Personalized programs designed to reduce falls in older people may make no difference to how often people fall, according to the most comprehensive research review to date.

21 Sep 2026

Adenine base editing slows neurodegeneration in hereditary motor neuron disease

A team of researchers led by Professor Haruhisa Inoue (Center for iPS Cell Research and Application, Kyoto University) and Professor Yuishin Izumi (Tokushima University) demonstrated that adenine base editing can correct a disease-causing genetic mutation and alleviate neurodegeneration in hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P), providing proof of concept for a precision gene therapy for inherited motor neuron diseases.

18 Sep 2026

Military blast exposure associated with long-term health conditions

Exposure to high-level blasts from incoming explosive devices or land mines among military veterans is associated with an increased risk of several conditions such as seizures, neuropathy and stroke years later, according to a study published September 16, 2026, in Neurology, the medical journal of the American Academy of Neurology.

16 Sep 2026

Psilocybin protects sensory nerves from chemotherapy damage in preclinical study

In mouse models, prophylactic psilocybin prevented or reduced multiple features of chemotherapy-induced peripheral neuropathy, with cycle-matched dosing sustaining protection during repeated cisplatin exposure without measurably affecting tumor growth. Experiments in human-derived sensory neurons and ex vivo peripheral nerves linked the effect to 5-HT2A-dependent preservation of mitochondrial trafficking and local axonal energy supply, while a nonhallucinogenic 5-HT2A agonist reproduced protection against mechanical hypersensitivity.

6 Sep 2026

Gestational diabetes history linked to earlier development of type 2 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that, in women that develop type 2 diabetes (T2D), those who had gestational diabetes (GD) when pregnant are developing T2D on average almost 13 years earlier than those who did not.

3 Sep 2026

Colorectal tumors may damage nerves before chemotherapy

Researchers at The University of Texas MD Anderson Cancer Center found that, in preclinical models of colorectal cancer, tumors can start damaging peripheral nerves before chemotherapy begins.

19 Aug 2026

Cocoa looks promising for mood, but the brain benefits come with a catch

A review of clinical and preclinical studies suggests cocoa polyphenols may support mood, neuroplasticity, cerebral blood flow, and gut-brain signaling through pathways involving BDNF/CREB, inflammation, and oxidative stress.

17 Aug 2026

Intertwined cellular processes reshape understanding of diabetes

A deeper understanding of how key cellular processes interact is reshaping perspectives on diabetes and its wide-ranging complications.

5 Aug 2026

Study explains long-term ocular symptoms following mild COVID-19

Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden.

8 Jul 2026

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded hazards of anxiety and depression than matched patients using naltrexone-bupropion. However, among adults without type 2 diabetes, tirzepatide was linked to higher recorded hazards of anxiety and insomnia than semaglutide, underscoring the need for cautious monitoring.

1 Jul 2026

Zebrafish model unlocks new insights into hereditary brain disease

CADASIL, an inherited disease caused by mutations in the NOTCH3 gene, damages the brain’s small blood vessels, leading to strokes, cognitive decline, and early dementia.

24 Jun 2026

New AI framework maps systemic obesity damage at cellular resolution

Researchers at Helmholtz Munich, the Ludwig Maximilians University Munich (LMU) and collaborating institutions have developed an artificial intelligence (AI) framework that maps disease-related changes throughout the entire mouse body at cellular resolution.

20 May 2026

Tumors exploit peripheral nerves to support cancer growth and spread

Tumors do not communicate only with immune cells, blood vessels, and stromal tissue. A growing body of evidence suggests that cancer can also co-opt the nervous system, reshaping the tumor microenvironment in ways that support growth, invasion, immune escape, and therapeutic resistance.

10 May 2026